Bozhena Saar-Ryss
YOU?
Author Swipe
View article: Drug-free in vitro activation of ovarian follicles and fresh tissue autotransplantation in patients with poor ovarian response and premature ovarian insufficiency
Drug-free in vitro activation of ovarian follicles and fresh tissue autotransplantation in patients with poor ovarian response and premature ovarian insufficiency Open
ClinicalTrials.gov (Identifier: NCT04024722).
View article: Clinical Outcome Using the Q300™ Device in a Reproductive Laboratory Environment: an open-label, non-controlled and non-randomized study
Clinical Outcome Using the Q300™ Device in a Reproductive Laboratory Environment: an open-label, non-controlled and non-randomized study Open
Background Infertility affects a significant portion of the global population, with male factor infertility contributing to nearly half of all cases. The success of assisted reproductive technologies (ART), such as in vitro fertilization (…
View article: First clinical pregnancy and delivery achieved after using a new 3D imaging technology for sperm selection: a case report
First clinical pregnancy and delivery achieved after using a new 3D imaging technology for sperm selection: a case report Open
Objective To report a case of a patient who, after experiencing recurrent failed implantations, underwent a novel technological intervention—using the Q300 device—which successfully led to a pregnancy and delivery of a healthy baby. Design…
View article: Risk of adverse pregnancy outcomes after abnormal hysterosalpingography
Risk of adverse pregnancy outcomes after abnormal hysterosalpingography Open
An abnormal HSG study was associated with adverse obstetrical outcomes. Specifically, uterine abnormalities increased the risk of preeclampsia and birthweight below 10th percentile, while tubal abnormalities were associated with a heighten…
View article: P-043 Preliminary clinical outcome using the Q300™ device in a reproductive laboratory environment
P-043 Preliminary clinical outcome using the Q300™ device in a reproductive laboratory environment Open
Study question How does the Q300™ Device impact clinical outcomes in a reproductive laboratory environment compared to established standards? Summary answer The device showed favorable clinical outcomes and was user-friendly. More research…
View article: Is there any truth in the myth that IVF treatments involve weight gain?
Is there any truth in the myth that IVF treatments involve weight gain? Open
Purpose To examine body weight change in women undergoing in vitro fertilization and embryo transfer (IVF-ET) using antagonist protocol after up to three treatment cycles. Methods A prospective cohort study among IVF patients treated betwe…
View article: Should a waiting period between consecutive IVF cycles be advised for normal or low responders?
Should a waiting period between consecutive IVF cycles be advised for normal or low responders? Open
The purpose of this study is to examine the impact of the time elapsed between repeated oocyte retrievals, on the number of oocytes retrieved, according to the ovarian response of the patient. This retrospective cohort study, found no corr…
View article: Stain-Free Sperm Analysis and Selection for Intracytoplasmic Sperm Injection Complying with WHO Strict Normal Criteria
Stain-Free Sperm Analysis and Selection for Intracytoplasmic Sperm Injection Complying with WHO Strict Normal Criteria Open
This multi-center study evaluated a novel microscope system capable of quantitative phase microscopy (QPM) for label-free sperm-cell selection for intracytoplasmic sperm injection (ICSI). Seventy-three patients were enrolled in four in vit…
View article: Methods to improve frozen-thawed blastocyst transfer outcomes- the IVF laboratory perspective
Methods to improve frozen-thawed blastocyst transfer outcomes- the IVF laboratory perspective Open
During the last few years, the number of frozen-thawed embryo transfer cycles (FET) significantly increased due to the universal application of more efficient cryopreservation techniques in the IVF laboratory and the improved survival rate…
View article: Novel non-toxic technology of sperm selection for ICSI comply with WHO strict normal criteria for stained sperm cells
Novel non-toxic technology of sperm selection for ICSI comply with WHO strict normal criteria for stained sperm cells Open
The authors have requested that this preprint be removed from Research Square.